Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | PPARA | Q07869 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | CETP | P11597 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15057124 | 0.85 | HPGD (0.45) | HPGDKMT2APPARGPPARAMGLL | |
| SCHEMBL15059092 | 0.79 | RIPK1 (0.40) | HPGDKMT2AMEN1PPARGPPARA | |
| SCHEMBL23519098 | 0.76 | PPARG (0.45) | HPGDKMT2AMEN1ATMPPARG | |
| SCHEMBL15545838 | 0.74 | KCNN4 (0.50) | HPGDKMT2AMEN1PPARGPPARA | |
| SCHEMBL15076071 | 0.74 | CETP (0.41) | HPGDKMT2APPARGPPARAMGLL | |
| SCHEMBL15546762 | 0.71 | POLB (0.49) | PPARGPPARAMRGPRX4 | |
| SCHEMBL8276072 | 0.70 | HDAC8 (0.61) | HDAC8 | |
| SCHEMBL14227143 | 0.68 | CETP (0.45) | HPGDKMT2AMEN1ATMPPARG | |
| SCHEMBL3373353 | 0.68 | PPARA (0.54) | KMT2AMEN1PPARGPPARACNR1 | |
| SCHEMBL13412201 | 0.68 | CES2 (0.53) | HPGDKMT2AMEN1OPRM1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9518045-B2 | Process for manufacturing benzoxazinones | BASF SE (DE) | 2016-12-13 | — | — | US | disclosed |
| US-9518045-B2 | Process for manufacturing benzoxazinones | BASF SE (DE) | 2016-12-13 | — | — | US | disclosed |
| US-9518045-B2 | Process for manufacturing benzoxazinones | BASF SE (DE) | 2016-12-13 | — | — | US | disclosed |
| EP-2885281-B1 | CARBAMAT-BENZOXAZINONES USEFUL FOR PREPARING TRIAZIN-BENZOXAZINONES | BASF SE (DE) | 2016-12-07 | — | — | EP | disclosed |
| EP-2885281-B1 | CARBAMAT-BENZOXAZINONES USEFUL FOR PREPARING TRIAZIN-BENZOXAZINONES | BASF SE (DE) | 2016-12-07 | — | — | EP | disclosed |
| EP-2794554-B1 | PROCESS FOR MANUFACTURING ARYLOXYACETAMIDES | BASF SE (DE) | 2016-08-17 | — | — | EP | disclosed |
| EP-2794554-B1 | PROCESS FOR MANUFACTURING ARYLOXYACETAMIDES | BASF SE (DE) | 2016-08-17 | — | — | EP | disclosed |
| EP-2885296-B1 | PROCESS FOR MANUFACTURING BENZOXAZINONES | BASF SE (DE) | 2016-06-29 | — | — | EP | disclosed |
| EP-2885296-B1 | PROCESS FOR MANUFACTURING BENZOXAZINONES | BASF SE (DE) | 2016-06-29 | — | — | EP | disclosed |
| US-9365495-B2 | Process for manufacturing aryloxyacetamides | BASF SE (DE) | 2016-06-14 | — | — | US | disclosed |
| US-20150119572-A1 | Process for Manufacturing Aryloxyacetamides | BASF SE (DE) | 2015-04-30 | — | — | US | disclosed |
| US-20150119572-A1 | Process for Manufacturing Aryloxyacetamides | BASF SE (DE) | 2015-04-30 | — | — | US | disclosed |
| US-20150119572-A1 | Process for Manufacturing Aryloxyacetamides | BASF SE (DE) | 2015-04-30 | — | — | US | disclosed |
| CN-104583186-A | Carbamate-benzoxazinones | BASF SE | 2015-04-29 | — | — | CN | disclosed |
| CN-104583205-A | Process for producing benzoxazinones | BASF SE | 2015-04-29 | — | — | CN | disclosed |
| EP-2794554-A1 | PROCESS FOR MANUFACTURING ARYLOXYACETAMIDES | BASF SE (DE) | 2014-10-29 | — | — | EP | disclosed |
| WO-2014026928-A1 | PROCESS FOR MANUFACTURING BENZOXAZINONES | BASF SE (DE) | 2014-02-20 | — | — | WO | disclosed |
| WO-2014026893-A1 | CARBAMAT-BENZOXAZINONES | BASF SE (DE) | 2014-02-20 | — | — | WO | disclosed |
| WO-2013092850-A1 | PROCESS FOR MANUFACTURING ARYLOXYACETAMIDES | BASF SE (DE) | 2013-06-27 | — | — | WO | disclosed |
| WO-2013092850-A1 | PROCESS FOR MANUFACTURING ARYLOXYACETAMIDES | BASF SE (DE) | 2013-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150119572-A1 | Process for Manufacturing Aryloxyacetamides | AADAC, CYP2E1, CYP1A2 | HPGD 302/4885KMT2A 793/4885MEN1 4829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.